semaglutide booster Weight loss drug could boost heart health of up to 93M patients in US alone Compound Semaglutide

Many insurance plans, however, will only pay for GLP-1s if a person has a diagnosis of diabetes, not obesity

As clinical evidence supporting GLP-1 medications for weight loss continues to mount, and as federal policy discussions around obesity treatment expand, more states are reconsidering whether Medicaid should cover weight loss drugs

Liver health: NAFLD and NASH Non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), represent a growing health concern globally

The short answer, supported by NHS and MHRA guidance, is that weight loss medications including GLP-1 receptor agonists (such as semaglutide and liraglutide), tirzepatide, naltrexone/bupropion, and orlistat are not recommended when you are trying to conceive